Cendres & Métaux SA – Trademark Portfolio
Entity Type: 03
Cendres & Métaux SA holds 8 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 7 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include SUPRALOC.
Rue de Boujean 122
CH-2501 Biel-Bienne
Showing of trademarks Trademarks
Trademark Classifications
Cendres & Métaux SA's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Precious metals and their alloys; jewellery, precious stones; horological instruments
Common metals and their alloys; metal building materials; transportable buildings of metal
Frequently Asked Questions
How many trademarks does Cendres & Métaux SA have?
Cendres & Métaux SA has 8 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 cancelled.
What trademark classes does Cendres & Métaux SA file in?
Cendres & Métaux SA files trademarks across 6 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 14 (Jewelry), Class 6 (Metal Goods). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are Cendres & Métaux SA's most well-known trademarks?
Cendres & Métaux SA's registered trademark portfolio includes well-known marks such as SUPRALOC. These are among 1 currently registered trademark in the portfolio.
What is Cendres & Métaux SA's trademark registration success rate?
Cendres & Métaux SA has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.